Tag Archives: Nordisks

Sales of Novo Nordisk’s injectable diabetes drugs including Ozempic have slowed sharply amid fierce competition and the threat of US tariffs, prompting it to cut costs and sharpen its commercial focus. The Danish drugmaker, whose booming sales of GLP-1 diabetes and obesity drugs in recent years had turned it into Europe’s most valuable company, has lost nearly $100bn (£75bn) in …

Novo Nordisk’s Earnings Come After a Dramatic Guidance Cut. What to Look for Now.  Barron’s Wegovy maker Novo Nordisk’s sales hike in second quarter  CNBC Novo Nordisk Before Q2 Earnings: How Should Investors Play the Stock?  Yahoo Finance Ozempic Maker’s Plight Shows Managing Markets Counts Too  Bloomberg.com Novo Nordisk is no longer a buy at UBS, which says compounding is here to stay  MarketWatch Source …